Evidence map

ReviewDrugs2015

Empagliflozin/Linagliptin: A Review in Type 2 Diabetes.

Esther S Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26323340